Elysium

company

About

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$40M
Industries
Health Care,Life Science,Personal Health,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs. It seeks to solve challenges in health with science, to help people live healthier and longer lives. It works directly with the scientists, clinicians, and health professionals around the world to identify and develop the natural compounds. Its product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$60M
Elysium has raised a total of $60M in funding over 2 rounds. Their latest funding was raised on Dec 23, 2019 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2019 Series C $40M 1 Detail
Dec 6, 2016 Series B $20M 1 General Catalyst Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Elysium is funded by 1 investors. General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
General Catalyst Series C